Disruption of social approach by MK-801, amphetamine, and fluoxetine in adolescent C57BL/6J mice

Neurotoxicology and Teratology

Volumn 36, Issue , 2013, Pages 36-46

  Moy, Sheryl S ^a   Nonneman, Randal J ^a   Shafer, Geoffrey O ^a   Nikolova, Viktoriya D ^a   Riddick, Natallia V ^a   Agster, Kara L ^a   Baker, Lorinda K ^a   Knapp, Darin J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Amphetamine; Autism; Ethanol withdrawal; Repetitive behavior; Social approach; Stereotypy

Indexed keywords

AMPHETAMINE; DIZOCILPINE; FLUOXETINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADOLESCENT; ALCOHOL WITHDRAWAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTISOCIAL BEHAVIOR; ARTICLE; AUTISM; COMPULSION; CONTROLLED STUDY; DECISION MAKING; LONG TERM EXPOSURE; MALE; MOLECULAR PATHOLOGY; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SOCIAL BEHAVIOR; SOCIAL INTERACTION; SOCIAL PREFERENCE; TASK PERFORMANCE;

AGING; AMPHETAMINE; ANIMALS; AUTISTIC DISORDER; BEHAVIOR, ANIMAL; DIZOCILPINE MALEATE; FLUOXETINE; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, N-METHYL-D-ASPARTATE; SEROTONIN UPTAKE INHIBITORS; SOCIAL BEHAVIOR;

MUS;

EID: 84875641398     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2012.07.007     Document Type: Article

References (79)

1. Abrahams B.S., Geschwind D.H. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 2008, 9:341-355.
2. Amodeo D.A., Jones J.H., Sweeney J.A., Ragozzino M.E. Differences in BTBR T+ tf/J and C57BL/6J mice on probabilistic reversal learning and stereotyped behaviors. Behav Brain Res 2012, 227:64-72.
3. Bailey A., Le Couteur A., Gottesman I., Bolton P., Simonoff E., Yuzda E., et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995, 25:63-77.
4. Balemans M.C., Huibers M.M., Eikelenboom N.W., Kuipers A.J., van Summeren R.C., Pijpers M.M., et al. Reduced exploration, increased anxiety, and altered social behavior: autistic-like features of euchromatin histone methyltransferase 1 heterozygous knockout mice. Behav Brain Res 2010, 208:47-55.
5. Basta-Kaim A., Fijal K., Budziszewska B., Regulska M., Leskiewicz M., Kubera M., et al. Prenatal lipopolysaccharide treatment enhances MK-801-induced psychotomimetic effects in rats. Pharmacol Biochem Behav 2011, 98:241-249.
6. Belzung C., Le Guisquet A.M., Barreau S., Calatayud F. An investigation of the mechanisms responsible for acute fluoxetine-induced anxiogenic-like effects in mice. Behav Pharmacol 2001, 12:151-162.
7. Chadman K.K. Fluoxetine, but not risperidone, increases sociability in the BTBR mouse model of autism. Pharmacol Biochem Behav 2011, 97:586-594.
8. Corbett R., Camacho F., Woods A.T., Kerman L.L., Fishkin R.J., Brooks K., et al. Antipsychotic agents antagonize non-competitive N-methyl-d-aspartate antagonist-induced behaviors. Psychopharmacology (Berl) 1995, 120:67-74.
9. Coutinho A.M., Sousa I., Martins M., Correia C., Morgadinho T., Bento C., et al. Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels. Hum Genet 2007, 121:243-256.
10. de Moura Linck V., Herrmann A.P., Goerck G.C., Iwu M.M., Okunji C.O., Leal MB Elisabetsky E. The putative antipsychotic alstonine reverses social interaction withdrawal in mice. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1449-1452.
11. Devlin B., Cook E.H., Coon H., Dawson G., Grigorenko E.L., McMahon W., et al. Autism and the serotonin transporter: the long and short of it. Mol Psychiatry 2005, 10:1110-1116.
12. Doyle C.A., McDougle C.J. Pharmacotherapy to control behavioral symptoms in children with autism. Expert Opin Pharmacother 2012, 13:1615-1629.
13. Duncan G.E., Moy S.S., Perez A., Eddy D.M., Zinzow W.M., Lieberman J.A., et al. Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function. Behav Brain Res 2004, 153:507-519.
14. Egashira N., Okuno R., Harada S., Matsushita M., Mishima K., Iwasaki K., et al. Effects of glutamate-related drugs on marble-burying behavior in mice: implications for obsessive-compulsive disorder. Eur J Pharmacol 2008, 586:164-170.
15. Feyder M., Karlsson R.M., Mathur P., Lyman M., Bock R., Momenan R., et al. Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams' syndrome. Am J Psychiatry 2010, 167:1508-1517.
16. File S.E., Andrews N., al-Farhan M. Anxiogenic responses of rats on withdrawal from chronic ethanol treatment: effects of tianeptine. Alcohol Alcohol 1993, 28:281-286.
17. Folstein S.E., Rosen-Sheidley B. Genetics of autism: complex aetiology for a heterogeneous disorder. Nat Rev Genet 2001, 2:943-955.
18. Fortier M.E., Joober R., Luheshi G.N., Boksa P. Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring. J Psychiatr Res 2004, 38:335-345.
19. Gao X.M., Elmer G.I., Adams-Huet B., Tamminga C.A. Social memory in mice: disruption with an NMDA antagonist and attenuation with antipsychotic drugs. Pharmacol Biochem Behav 2009, 92:236-242.
20. Gendreau P.L., Petitto J.M., Gariepy J.L., Lewis M.H. D2-like dopamine receptor mediation of social-emotional reactivity in a mouse model of anxiety: strain and experience effects. Neuropsychopharmacology 1998, 18:210-221.
21. Gendreau P.L., Petitto J.M., Petrova A., Gariepy J., Lewis M.H. D(3) and D(2) dopamine receptor agonists differentially modulate isolation-induced social-emotional reactivity in mice. Behav Brain Res 2000, 114:107-117.
22. Geschwind D.H. Genetics of autism spectrum disorders. Trends Cogn Sci 2011, 15:409-416.
23. Gingrich J.A., Hen R. Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology (Berl) 2001, 155:1-10.
24. Gorman J.M., Liebowitz M.R., Fyer A.J., Goetz D., Campeas R.B., Fyer M.R., et al. An open trial of fluoxetine in the treatment of panic attacks. J Clin Psychopharmacol 1987, 7:329-332.
25. Gould G.G., Hensler J.G., Burke T.F., Benno R.H., Onaivi E.S., Daws L.C. Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior. J Neurochem 2011, 116:291-303.
26. Graham D.L., Amos-Kroohs R.M., Braun A.A., Grace C.E., Schaefer T.L., Skelton M.R., et al. Neonatal (+)-methamphetamine exposure in rats alters adult locomotor responses to dopamine D1 and D2 agonists and to a glutamate NMDA receptor antagonist, but not to serotonin agonists. Int J Neuropsychopharmacol 2012, 1-15.
27. Halene T.B., Ehrlichman R.S., Liang Y., Christian E.P., Jonak G.J., Gur T.L., et al. Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia. Genes Brain Behav 2009, 8:661-675.
28. Hallmayer J., Cleveland S., Torres A., Phillips J., Cohen B., Torigoe T., et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 2011, 68:1095-1102.
29. Herbert M.R., Russo J.P., Yang S., Roohi J., Blaxill M., Kahler S.G., et al. Autism and environmental genomics. Neurotoxicology 2006, 27:671-684.
30. Homberg J.R., Schiepers O.J., Schoffelmeer A.N., Cuppen E., Vanderschuren L.J. Acute and constitutive increases in central serotonin levels reduce social play behaviour in peri-adolescent rats. Psychopharmacology (Berl) 2007, 195:175-182.
31. Insel T.R., Winslow J.T. Serotonin and neuropeptides in affiliative behaviors. Biol Psychiatry 1998, 44:207-219.
32. Jimenez-Gomez C., Osentoski A., Woods J.H. Pharmacological evaluation of the adequacy of marble burying as an animal model of compulsion and/or anxiety. Behav Pharmacol 2011, 22:711-713.
33. Kistner-Griffin E., Brune C.W., Davis L.K., Sutcliffe J.S., Cox N.J., Cook E.H. Parent-of-origin effects of the serotonin transporter gene associated with autism. Am J Med Genet B Neuropsychiatr Genet 2010, 156:139-144.
34. Knapp D.J., Overstreet D.H., Moy S.S., Breese G.R. SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats. Alcohol 2004, 32:101-111.
35. Labrie V., Lipina T., Roder J.C. Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia. Psychopharmacology (Berl) 2008, 200:217-230.
36. Libbey J.E., Sweeten T.L., McMahon W.M., Fujinami R.S. Autistic disorder and viral infections. J Neurovirol 2005, 11:1-10.
37. Londei T., Valentini A.M., Leone V.G. Investigative burying by laboratory mice may involve non-functional, compulsive, behaviour. Behav Brain Res 1998, 94:249-254.
38. Malkova N.V., Yu C.Z., Hsiao E.Y., Moore M.J., Patterson P.H. Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. Brain Behav Immun 2012, 26:607-616.
39. Mehta M.V., Gandal M.J., Siegel S.J. mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism. PLoS One 2011, 6:e26077.
40. Mohn A.R., Gainetdinov R.R., Caron M.G., Koller B.H. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999, 98:427-436.
41. Moy S.S., Breese G.R. Phencyclidine supersensitivity in rats with neonatal dopamine loss. Psychopharmacology (Berl) 2002, 161:255-262.
42. Moy S.S., Knapp D.J., Criswell H.E., Breese G.R. Flumazenil blockade of anxiety following ethanol withdrawal in rats. Psychopharmacology (Berl) 1997, 131:354-360.
43. Moy S.S., Nadler J.J., Perez A., Barbaro R.P., Johns J.M., Magnuson T.R., et al. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav 2004, 3:287-302.
44. Moy S.S., Nadler J.J., Young N.B., Perez A., Holloway L.P., Barbaro R.P., et al. Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav Brain Res 2007, 176:4-20.
45. Moy S.S., Nadler J.J., Poe M.D., Nonneman R.J., Young N.B., Koller B.H., et al. Development of a mouse test for repetitive, restricted behaviors: relevance to autism. Behav Brain Res 2008, 188:178-194.
46. Moy S.S., Nadler J.J., Young N.B., Nonneman R.J., Grossman A.W., Murphy D.L., et al. Social approach in genetically-engineered mouse lines relevant to autism. Genes Brain Behav 2008, 8:129-142.
47. Moy S.S., Ghashghaei H.T., Nonneman R.J., Weimer J.M., Yokota Y., Lee D., et al. Deficient NRG1-ERBB signaling alters social approach: relevance to genetic mouse models of schizophrenia. J Neurodevelop Disord 2009, 1:302-312.
48. Moy S.S., Nikolova V.D., Riddick N.V., Baker L.K., Koller B.H. Preweaning Sensorimotor Deficits and Adolescent Hypersociability in Grin1 Knockdown Mice. Dev Neurosci 2012, 34:159-173.
49. Nadler J.J., Moy S.S., Dold G., Trang D., Simmons N., Perez A., et al. Automated apparatus for rapid quantitation of autism-like social deficits in mice. Genes Brain Behav 2004, 3:303-314.
50. Nilsson M., Waters S., Waters N., Carlsson A., Carlsson M.L. A behavioural pattern analysis of hypoglutamatergic mice - effects of four different antipsychotic agents. J Neural Transm 2001, 108:1181-1196.
51. Nilsson M., Markinhuhta K.R., Carlsson M.L. Differential effects of classical neuroleptics and a newer generation antipsychotics on the MK-801 induced behavioural primitivization in mouse. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:521-530.
52. Ozawa K., Hashimoto K., Kishimoto T., Shimizu E., Ishikura H., Iyo M. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiatry 2006, 59:546-554.
53. Palmer R.F., Blanchard S., Stein Z., Mandell D., Miller C. Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas. Health Place 2006, 12:203-209.
54. Parnell S.E., Chen S.Y., Charness M.E., Hodge C.W., Dehart D.B., Sulik K.K. Concurrent dietary administration of D-SAL and ethanol diminishes ethanol's teratogenesis. Alcohol Clin Exp Res 2007, 31:2059-2064.
55. Pierce K., Courchesne E. Evidence for a cerebellar role in reduced exploration and stereotyped behavior in autism. Biol Psychiatry 2001, 49:655-664.
56. Rasalam A.D., Hailey H., Williams J.H., Moore S.J., Turnpenny P.D., Lloyd D.J., et al. Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev Med Child Neurol 2005, 47:551-555.
57. Riddick N.V., Agster L.K., Baker L.K., Koller B.H., Moy S.S. Marble-burying as an index of restricted interests in mouse models of repetitive behavior. Soc Neurosci Abstr 2011, 41:56.10.
58. Riedel G., Kang S.H., Choi D.Y., Platt B. Scopolamine-induced deficits in social memory in mice: reversal by donepezil. Behav Brain Res 2009, 204:217-225.
59. Rodriguiz R.M., Chu R., Caron M.G., Wetsel W.C. Aberrant responses in social interaction of dopamine transporter knockout mice. Behav Brain Res 2004, 148:185-198.
60. Rosenberg R.E., Law J.K., Yenokyan G., McGready J., Kaufmann W.E., Law P.A. Characteristics and concordance of autism spectrum disorders among 277 twin pairs. Arch Pediatr Adolesc Med 2009, 163:907-914.
61. Rubenstein J.L. Three hypotheses for developmental defects that may underlie some forms of autism spectrum disorder. Curr Opin Neurol 2010, 23:118-123.
62. Sasson N.J., Turner-Brown L.M., Holtzclaw T.N., Lam K.S., Bodfish J.W. Children with autism demonstrate circumscribed attention during passive viewing of complex social and nonsocial picture arrays. Autism Res 2008, 1:31-42.
63. Shelton J.F., Hertz-Picciotto I., Pessah I.N. Tipping the balance of autism risk: potential mechanisms linking pesticides and autism. Environ Health Perspect 2012, 120:944-951.
64. Shi L., Fatemi S.H., Sidwell R.W., Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 2003, 23:297-302.
65. Shmelkov S.V., Hormigo A., Jing D., Proenca C.C., Bath K.G., Milde T., et al. Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice. Nat Med 2010, 16:598-602.
66. Steinpreis R.E., Sokolowski J.D., Papanikolaou A., Salamone J.D. The effects of haloperidol and clozapine on PCP- and amphetamine-induced suppression of social behavior in the rat. Pharmacol Biochem Behav 1994, 47:579-585.
67. Sutcliffe J.S., Delahanty R.J., Prasad H.C., McCauley J.L., Han Q., Jiang L., et al. Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am J Hum Genet 2005, 77:265-279.
68. Takeuchi H., Yatsugi S., Yamaguchi T. Effect of YM992, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT 2A receptor antagonistic activity, on a marble-burying behavior test as an obsessive-compulsive disorder model. Jpn J Pharmacol 2002, 90:197-200.
69. Thomas A., Burant A., Bui N., Graham D., Yuva-Paylor L.A., Paylor R. Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. Psychopharmacology (Berl) 2009, 204:361-373.
70. Tian Y., Green P.G., Stamova B., Hertz-Picciotto I., Pessah I.N., Hansen R., et al. Correlations of gene expression with blood lead levels in children with autism compared to typically developing controls. Neurotox Res 2011, 19:1-13.
71. Uz T., Dimitrijevic N., Akhisaroglu M., Imbesi M., Kurtuncu M., Manev H. The pineal gland and anxiogenic-like action of fluoxetine in mice. Neuroreport 2004, 15:691-694.
72. Voineagu I., Wang X., Johnston P., Lowe J.K., Tian Y., Horvath S., et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011, 474:380-384.
73. Volk H.E., Hertz-Picciotto I., Delwiche L., Lurmann F., McConnell R. Residential proximity to freeways and autism in the CHARGE study. Environ Health Perspect 2011, 119:873-877.
74. Vorhees C.V., Graham D.L., Braun A.A., Schaefer T.L., Skelton M.R., Richtand N.M., Williams M.T. Prenatal immune challenge in rats: Altered responses to dopaminergic and glutamatergic agents, prepulse inhibition of acoustic startle, and reduced route-based learning as a function of maternal body weight gain after prenatal exposure to Poly IC. Synapse 2012, 66:725-737.
75. Wassink T.H., Hazlett H.C., Epping E.A., Arndt S., Dager S.R., Schellenberg G.D., et al. Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism. Arch Gen Psychiatry 2007, 64:709-717.
76. Williams G., King J., Cunningham M., Stephan M., Kerr B., Hersh J.H. Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol 2001, 43:202-206.
77. Wills T.A., Knapp D.J., Overstreet D.H., Breese G.R. Interactions of stress and CRF in ethanol-withdrawal induced anxiety in adolescent and adult rats. Alcohol Clin Exp Res 2010, 34:1603-1612.
78. Zhuang X., Gross C., Santarelli L., Compan V., Trillat A.C., Hen R. Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors. Neuropsychopharmacology 1999, 21:52S-60S.
79. Zuckerman L., Rehavi M., Nachman R., Weiner I. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 2003, 28:1778-1789.